Author: Zhejiang Difference Biological Technology Co., Ltd

Posted Date:

February 9, 2026

DIFF Biotech’s Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway

Zhejiang Difference Biological Technology Co., Ltd

February 9, 2026